IL-6 inhibition offers new hope for RA patients

Greg Baxter talks to Dr Ernest Choy — one of the world's foremost experts in Rheumatoid Arthritis — who says new drugs offer hope for RA patients. Eight years ago, Dr Ernest Choy was studying anti-TNF treatments for patients with rheumatoid arthritis (RA) at a clinical trials unit at King’s College London – a unit he established – when colleagues from Japan approached him about running a clinical trial on an alternative. It was hoped that the alternative – inhibition of a biochemical messenger that regulates inflammation – would provide treatment for people with RA who could not tolerate anti-TNF…